Clincosm LogoSign in Get a demo

Non-alcoholic Steatohepatitis

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Non-alcoholic Steatohepatitis Trial (Rosuvastatin 20mg, N-acetyl cysteine, Rosuvastatin and N-acetyl cysteine)

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Rosuvastatin 20mg
  • +3 more
  • (no location specified)
Oct 29, 2023

NON-ALCOHOLIC STEATOHEPATITIS Trial in United States (DA-1241, Sitagliptin, DA-1241 Placebo)

Recruiting
  • NON-ALCOHOLIC STEATOHEPATITIS
  • Rialto, California
  • +5 more
Sep 19, 2023

Non-alcoholic Steatohepatitis, Hepatic Impairment Trial (Efinopegdutide)

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Hepatic Impairment
  • (no location specified)
Sep 18, 2023

Non-alcoholic Steatohepatitis Trial (INI-822 (A), Placebo (B))

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • INI-822 (A)
  • Placebo (B)
  • (no location specified)
Jul 6, 2023

Non-alcoholic Steatohepatitis Trial (AZD9550, Placebo)

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • (no location specified)
Apr 27, 2023

Non-alcoholic Steatohepatitis, Hepatic Impairment, Cirrhosis Trial in Orlando, San Antonio, Kistarcsa (TVB-2640 - 50 mg)

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • +2 more
  • TVB-2640 - 50 mg
  • Orlando, Florida
  • +2 more
Apr 17, 2023

Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Mar 9, 2023

Europe: Findings From a Multidisciplinary HCP-survey

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Non-alcoholic Fatty Liver Disease
  • No treatment given
  • Bangalore, India
    Novo Nordisk Investigational Site
Mar 9, 2023

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Mar 1, 2023

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Obesity Trial in Boston (Endoscopic ultrasound shear wave

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • Endoscopic ultrasound shear wave elastography
  • Boston, Massachusetts
  • +1 more
Feb 13, 2023

Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis Trial in Phoenix (Investigational Liver Fat Quantification

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Investigational Liver Fat Quantification Software
  • Phoenix, Arizona
    Phoenix Children's Hospital
Jan 31, 2023

Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)

Recruiting
  • Non-alcoholic Steatohepatitis
  • Berlin, Germany
    Research Site
Jan 16, 2023

Non-alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Trial in Chandler, Peoria

Completed
  • Non-alcoholic Steatohepatitis
  • +2 more
  • BT-NCBT-00X
  • Chandler, Arizona
  • +1 more
Dec 12, 2022

Non-alcoholic Steatohepatitis Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Non-alcoholic Steatohepatitis
  • Huntsville, Alabama
  • +369 more
Nov 23, 2022

CHronic Hepatopathies Associated With ALcohol Consumption aNd

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +4 more
  • Liver biopsy
  • (no location specified)
Nov 12, 2022

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Glucose Metabolism Disorders Trial in Aarhus (glucagon)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • glucagon
  • Aarhus, Danmark, Denmark
    Aarhus University Hospital
Nov 3, 2022

Non-alcoholic Steatohepatitis Trial in Tanta (Obeticholic Acid Oral Tablet, Vit E)

Active, not recruiting
  • Non-alcoholic Steatohepatitis
  • Obeticholic Acid Oral Tablet
  • Vit E
  • Tanta, Egypt
    Department of Tropical Medicine and Infectious Diseases, Faculty
Oct 6, 2022

Non-alcoholic Steatohepatitis, Type 2 Diabetes (T2DM), Chronic Kidney Disease Trial in Ruddington (cotadutide solution for

Completed
  • Non-alcoholic Steatohepatitis
  • +2 more
  • cotadutide solution for injection
  • Ruddington, United Kingdom
    Research Site
Sep 30, 2022

Non-Alcoholic Steatohepatitis Trial in Ankara (resistance and aerobic exercise, physical activity recommendation)

Recruiting
  • Non-Alcoholic Steatohepatitis
  • resistance and aerobic exercise
  • physical activity recommendation
  • Ankara, Turkey
    Hacettepe University, Faculty of Physical Therapy and Rehabilita
Aug 16, 2022

Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis Trial in Hangzhou (2mg of ASC41, 4mg of ASC41 (2 tablets of 2

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • Non-alcoholic Steatohepatitis
  • 2mg of ASC41
  • +2 more
  • Hangzhou, Zhejiang, China
    The affiliated Hospital of Hangzhou Normal University
Jul 13, 2022

Non-alcoholic Steatohepatitis, Fatty Liver, Fibrosis, Liver Trial in San Antonio (Nitazoxanide 500mg BID)

Completed
Has Results
  • Non-alcoholic Steatohepatitis
  • +3 more
  • Nitazoxanide 500mg BID
  • San Antonio, Texas
    Pinnacle Clinical Research
Jun 29, 2022

Non-Alcoholic Steatohepatitis Trial in China (HEC96719, Placebo)

Recruiting
  • Non-Alcoholic Steatohepatitis
  • Beijing, Beijing, China
  • +8 more
May 25, 2022

Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis Trial in Boston, Boardman (Investigational Liver Fat

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Investigational Liver Fat Quantification Software
  • Boston, Massachusetts
  • +2 more
May 23, 2022

Assessment of Fatty Liver With Thermo-acoustic Device

Not yet recruiting
  • NASH
  • +6 more
  • Thermo-acuostic image acquisition of liver
  • MRI-PDFF estimation of hepatic fat
  • Milwaukee, Wisconsin
    Froedtert Hospital
May 23, 2022